Asian Pacific Journal of Cancer Prevention · 2015 · 17 citations · 28 references
MedicineGeneticsOncologyCancer GeneticsEpigeneticsMolecular OncologyCancer EpigeneticsCancer EtiologyCancer RiskDna Methylation ProfilingEpigenetic Regulation In CancerLung CancerBiomarker-based Risk PredictionCancer Epigenetic BiomarkersCancer Risk AssociationEpigenetic Risk PredictionLung Cancer RiskMolecular Risk MarkersPromoter MethylationRisk
In order to explore the association between cadherin 13 (CDH13) gene promoter methylation and lung carcinoma (LC) risk, we carried out a meta-analysis with searching of PubMed, Web of Science. Ultimately, 17 articles were identified and analysised by STATA 12.0 software. Overall, we found a significant relationship between CDH13 promoter methylation and LC risk (odds ratio=6.98, 95% confidence interval: 4.21-11.56, p<0.001). Subgroup analyses further revealed that LC risk was increased for individuals carrying the methylated CDH13 compared with those with unmethylated CDH13. Hence, our study identified a strong association between CDH13 gene promoter methylation and LC and highlighted a promising potential for CDH13 methylation in LC risk prediction.
28
Bias in meta-analysis detected by a simple, graphical test
Matthias Egger, George Davey Smith, Martin Schneider et al. · BMJ · 1997 · 56.3K citations
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Meta-analysis in clinical trials
Rebecca DerSimonian, Nan M. Laird · Controlled Clinical Trials · 1986 · 39.3K citations